Developing a diagnostic test to identify the selected mutation within the CFTR gene that determines the onset of cystic fibrosis

1. Dequeker E, Cuppens H, Dodge J, Estivill X, Goossens M, Pignatti PF, et al. Recommendations for quality improvement in genetic testing for cystic fibrosis European Concerted Action on Cystic Fibrosis. Eur J Hum Genet. 2000;8(2):S2-24.10.1038/sj.ejhg.520048711108532Search in Google Scholar

2. Dork T, Macek M, Mekus F, Tümmler B, Tzountzouris J, Casals T, et al. Characterization of a novel 21 - kb delection CFTR dele 2, 3 (21kb) in the CFTR gene: a cystic fibrosis mutation on Slavic orgin in common in Central and East Europe. Hum Genet. 2000;106:259-68.10.1007/s00439000024610798353Search in Google Scholar

3. Stężowska-Kubiak S. Epidemiological and clinical characteristics of the Polish population of patients suffering from cystic fibrosis. 2011.Search in Google Scholar

4. Bal J, Maciejko D, Mazurczak T, Potocka A, Krawczak M, Reiss J. Frequency of the cystic fibrosis mutation delta F508 in Poland. Hum Genet. 1991;86:329.10.1007/BF002024241997393Search in Google Scholar

5. Pogorzelski A, Witt M, Bal J. CFTR gene mutations in patients with cystic fibrosis in Poland. Acta Pneumono Allergol Ped. 1998;2:5-8.Search in Google Scholar

6. Witt M, Bal J, Maciejko D, Mazurczak T. Incidence of CFTR gene mutations in patients with cystic fibrosis in Poland. Pediatr Pol. 1997;72:665-8.Search in Google Scholar

7. Bobadilla J, Macek M Jr., Fine J, Farel P. Cystic Fibrosis: a worldwide analysis of CFTR mutations – correlation with incidence data and application to screening. Hum Genet. Mut. 2002;19:575-606.10.1002/humu.1004112007216Search in Google Scholar

8. French CF Registry – Annual Data Report 2007. Paris: Vaincre la Mucoviscidose and INED; 2010.Search in Google Scholar

9. UK CF Registry Annual Data Report 2008. Cystic Fibrosis Trust; 2009.Search in Google Scholar

10. Annual Report 2007. The Cystic Fibrosis Registry of Ireland; 2009.Search in Google Scholar

11. Cystic Fibrosis in Australia 2008. 11th annual report from the Australian Cystic Fibrosis Data Registry. Australia: Cystic Fibrosis; 2010.Search in Google Scholar

12. www.cysticfibrosis.caSearch in Google Scholar

13. Sens B, Stern M. Qualitätssicherung Mukoviszidose. Überlich über den Gesundheitszustand der Patient in Deutschland 2009. Hippocampus Verlag KG;2010.Search in Google Scholar

14. Shamseer L, Adams D, Brown N, Johnson JA, Vohra S. Antioxidant micronutrients for lung disease in cystic fibrosis. Cochrane Database Syst Rev. 2010;12:CD007020. DOI: 10.1002/14651858.CD007020. pub2.10.1002/14651858.CD007020.pub221154377Open DOISearch in Google Scholar

15. Sanchez-Garcia J, Benet J, Gutierrez-Mateo C, Luís Séculi J, Monrós E, Navarro J. Multiple mutation analysis of the cystic fibrosis gene a single cells. Mol Hum Reprod. 2005;11:463-8.10.1093/molehr/gah17615908456Search in Google Scholar

16. Dreesen J, Jacobs L, Bras M, Herbergs J, Dumolin JCM, Geraedts JPM et al. Multiplex PCR of polymorphic markers flanking the CFTR gene; a general approach for pre-implantation genetic diagnosis of cystic fibrosis. Mol Hum Reprod. 2000;6:391-6.10.1093/molehr/6.5.39110775641Search in Google Scholar

17. Moutou C, Gardes N, Viville S. Multiplex PCR combining deltaF508 mutation and intragenic microsatellites of the CFTR gene for preimplantation genetic diagnosis (PGD) of cystic fibrosis. Eur J Hum Genet. 2002;10:231-8.10.1038/sj.ejhg.520079412032730Search in Google Scholar

18. Goosens V, Sermon K, Lissens W, De Rycke M, Saerens B, De Vos A, et al. Improving clinical preimplantation genetic diagnosis for cystic fibrosis by duplex PCR using two polymorphic markers or one polymorphic marker in combination with the detection of the DF508 mutation. Mol Hum Reprod. 2003;9:559-67.10.1093/molehr/gag06512900515Search in Google Scholar